It turns out that Moderna received $2.5 billion in funding from the USA. $1 billion was given a while ago, and now $1.5 billion was allocated a couple of weeks ago. Approximately half of this amount will be granted upon successful development and market launch of 100 million COVID-19 vaccines (mRNA-1273). The article states that similar agreements (now without details on the amounts) exist with Johnson & Johnson, AstraZeneca Plc, Pfizer Inc, BioNTech SE, Sanofi SA, and GlaxoSmithKline Plc, to reach the necessary 500 million vaccines.
It was also found that RNA vaccines — specifically those being developed by Moderna — have not yet been released for human use by anyone. There are about 100 vector vaccines, like the one currently being produced by Gamaleya, (both released and in trial phases, according to clinicaltrials.gov). As for RNA vaccines approved for human use, there are none yet.
A good dashboard for vaccines:
An excellent (but now quite outdated) overview: https://meduza.io/feature/2020/05/08/ischerpyvayuschiy-nu-pochti-putevoditel-meduzy-po-vsemu-chto-uzhe-izvestno-o-vaktsinah-protiv-covid-19-kogda-gde-i-kakimi-oni-budut
https://finance.yahoo.com/news/u-inks-1-5-billion-020816629.html
Hi, I'm Rauf Aliev. 